XML 77 R69.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income (Loss) Per Share - Summary of Calculation of Diluted Net Income (Loss) Per Share (Parenthetical) (Details) - $ / shares
6 Months Ended
Jun. 30, 2025
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares converted in to notes 2,222,222      
Number of shares converted in to option     3,702,360  
Warrants exercisable price per share     $ 15  
Warrants outstanding       0
March 2025 Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants outstanding     925,590  
Series A [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of warrants related to legacy 869,565      
Warrants exercisable price per share $ 12.5      
Series C [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of warrants related to legacy 869,565      
Warrants exercisable price per share $ 9      
FTAC Emerald [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of warrants related to legacy   12,434,658    
Warrants exercisable price per share   $ 11.5